Canada Life’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-7,371
| Closed | -$116K | – | 2009 |
|
|
2024
Q4 | $116K | Buy |
7,371
+4,976
| +208% | +$78.3K | ﹤0.01% | 1790 |
|
|
2024
Q3 | $139K | Sell |
2,395
-5,425
| -69% | -$315K | ﹤0.01% | 1815 |
|
|
2024
Q2 | $358K | Buy |
7,820
+2,603
| +50% | +$119K | ﹤0.01% | 1748 |
|
|
2024
Q1 | $345K | Buy |
5,217
+2,822
| +118% | +$187K | ﹤0.01% | 1752 |
|
|
2023
Q4 | $95K | Hold |
2,395
| – | – | ﹤0.01% | 1954 |
|
|
2023
Q3 | $76K | Buy |
2,395
+1,497
| +167% | +$47.5K | ﹤0.01% | 2019 |
|
|
2023
Q2 | $36K | Hold |
898
| – | – | ﹤0.01% | 2043 |
|
|
2023
Q1 | $38K | Hold |
898
| – | – | ﹤0.01% | 2108 |
|
|
2022
Q4 | $43K | Buy |
898
+399
| +80% | +$19.1K | ﹤0.01% | 2101 |
|
|
2022
Q3 | $19K | Hold |
499
| – | – | ﹤0.01% | 2275 |
|
|
2022
Q2 | $14K | Hold |
499
| – | – | ﹤0.01% | 2328 |
|
|
2022
Q1 | $29K | Hold |
499
| – | – | ﹤0.01% | 2283 |
|
|
2021
Q4 | $29K | Hold |
499
| – | – | ﹤0.01% | 2299 |
|
|
2021
Q3 | $20K | Hold |
499
| – | – | ﹤0.01% | 2440 |
|
|
2021
Q2 | $21K | Hold |
499
| – | – | ﹤0.01% | 2476 |
|
|
2021
Q1 | $30K | Hold |
499
| – | – | ﹤0.01% | 2442 |
|
|
2020
Q4 | $35K | Buy |
+499
| New | +$35K | ﹤0.01% | 2396 |
|